·Department of Reproduction, Peking University Shenzhen Hospital
· UFG Director of Kyrgyzstan International Reproductive Hospital
·Doctor of Medicine/Doctor of Science, Peking University and UCLA, USA
·National Public-funded Joint Training Doctoral Scholarship Winners
·Winner of Peking University Academic Star Award.
is good at treating infertility caused by polycystic ovary syndrome (PCOS). The unique "anti-anti-sensitization and sensitization" therapy can successfully help most patients with polycystic ovary to resume normal ovarian cycles, obtain sufficient high-quality eggs, and achieve excellent pregnancy outcomes.
is good at treating mild premature ovarian failure, treating infertility caused by premature ovarian failure through autologous stem cell transplantation, and improving the outcome of pregnancy born in the egg.
The unique "comprehensive test-tube" therapy specializes in solving the fertility problems of patients aged 30 to 39 with premature ovarian failure.
is good at the formulation and monitoring of individualized ovarian ovulation promotion plans, and insists on direct management of all elements in the entire process from ovulation promotion to egg retrieval to embryo culture.
is good at treating infertility, biochemical pregnancy and repeated implantation failure caused by thin endometrium through autologous stem cell transplantation.